Employment-contingent health insurance, illness, and labor supply of women: evidence from married women with breast cancer

Department of Health Administration and Massey Cancer Center, Virginia Commonwealth University, USA.
Health Economics (Impact Factor: 2.14). 07/2007; 16(7):719-37. DOI: 10.1002/hec.1191
Source: PubMed

ABSTRACT We examine the effects of employment-contingent health insurance (ECHI) on married women's labor supply following a health shock. First, we develop a theoretical framework that examines the effects of ECHI on the labor supply response to a health shock, which suggests that women with ECHI are less likely to reduce their labor supply in response to a health shock, relative to women with health insurance through their spouse's employer. Second, we empirically examine this relationship based on labor supply responses to breast cancer. We find that health shocks decrease labor supply to a greater extent among women insured by their spouse's policy than among women with health insurance through their own employer, suggesting that ECHI creates incentives to remain working when faced with a serious illness.


Available from: Zhehui Luo, Jan 08, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In prior research, we found modest labor supply impacts on employment of women newly diagnosed with breast cancer. Given the short-and long-term disabilities associated with breast cancer and its treatment, in this paper we investigate the influence of workplace accommodations on employment and hours worked of these women. Accommodations that allow women to work fewer hours or ease the burden of work could also generate health benefits by reducing workplace demands and allowing women more time to tend to treatment needs and recovery. Our evidence suggests that some accommodations appear to impact hours worked negatively, and some affect hours and employment positively. In addition, some of the accommodations that appear to reduce hours of work are associated with positive health benefits. Acknowledgements
  • [Show abstract] [Hide abstract]
    ABSTRACT: This analysis describes the long-term workforce participation patterns of individuals diagnosed with head and neck cancer (HNC).
    Journal of Cancer Survivorship 07/2014; DOI:10.1007/s11764-014-0382-2 · 3.29 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the financial experiences of a racially and ethnically diverse cohort of long-term breast cancer survivors (17% African American, 40% Latina) identified through population-based registries. Longitudinal study of women diagnosed with nonmetastatic breast cancer in 2005 to 2007 and reported to the SEER registries of metropolitan Los Angeles and Detroit. We surveyed 3,133 women approximately 9 months after diagnosis and 4 years later. Multivariable models evaluated correlates of self-reported decline in financial status attributed to breast cancer and of experiencing at least one type of privation (economically motivated treatment nonadherence and broader hardships related to medical expenses). Among 1,502 patients responding to both surveys, median out-of-pocket expenses were ≤ $2,000; 17% of respondents reported spending > $5,000; 12% reported having medical debt 4 years postdiagnosis. Debt varied significantly by race: 9% of whites, 15% of blacks, 17% of English-speaking Latinas, and 10% of Spanish-speaking Latinas reported debt (P = .03). Overall, 25% of women experienced financial decline at least partly attributed to breast cancer; Spanish-speaking Latinas had significantly increased odds of this decline relative to whites (odds ratio [OR], 2.76; P = .006). At least one privation was experienced by 18% of the sample; blacks (OR, 2.6; P < .001) and English-speaking Latinas (OR, 2.2; P = .02) were significantly more likely to have experienced privation than whites. Racial and ethnic minority patients appear most vulnerable to privations and financial decline attributable to breast cancer, even after adjustment for income, education, and employment. These findings should motivate efforts to control costs and ensure communication between patients and providers regarding financial distress, particularly for vulnerable subgroups.
    Journal of Clinical Oncology 03/2014; 32(12). DOI:10.1200/JCO.2013.53.0956 · 17.88 Impact Factor